Logo

Quidel

JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More

Highlights of the third day included Quantum-Si's plans for its protein sequencing platform and strategic initiatives from Opko's BioReference Laboratories. 

Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates

For the fourth quarter of 2021, the firm expects COVID-19 revenues of approximately $510 million and total revenues of $633 million to $637 million.

GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets

The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.

Quidel Q3 Revenues Up 7 Percent, Beat Analysts' Estimate

Quidel's molecular diagnostic solutions business revenues fell 13 percent due in part to a decline in sales of Lyra PCR assays for COVID-19 diagnosis.

Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate

Quidel expects approximately $406.0 million in COVID-19 revenues compared with $375.7 million a year ago.

Oct 1, 2021

GenomeWeb Index Takes 7 Percent Tumble in September

Aug 5, 2021

Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates

Jul 26, 2021

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business

Jul 19, 2021

OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer

Jul 12, 2021

Quidel Nabs CE Mark for Savanna Analyzer, Respiratory Panel

Jul 7, 2021

Quidel Recalls Lyra SARS-CoV-2 Test Due to Potential False Negative Results

Jun 1, 2021

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

Apr 23, 2021

Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations

Mar 10, 2021

Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand

Mar 2, 2021

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Feb 19, 2021

Quidel Reports Delay in OTC COVID-19 Antigen Test Claims, Pours Cold Water on M&A Rumors
Premium

Feb 18, 2021

Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates

Feb 1, 2021

Fulgent Genetics Soars in January as GenomeWeb Index Begins 2021 up 10 Percent

Jan 13, 2021

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Jan 7, 2021

Quidel Preliminary Q4 Revenues Up Fivefold

Dec 23, 2020

Quidel Gets EUA for Rapid, Extraction-Free COVID-19 MDx on Solana System

Dec 1, 2020

Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth

Oct 30, 2020

Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'
Premium

Oct 29, 2020

Quidel Q3 Revenues More Than Triple, Beat Analyst Expectations

Oct 1, 2020

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Breaking News
The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.